Summary: When most people think about health care reform, legislation comes to mind, the American Reinvestment and Recovery Act and the Patient Protection and Affordable Care Act. But for life sciences companies, health reform is a catalyst, not a forcing function. They are on the cusp of significant transformation in terms of reimbursement, access to products and impacts to innovation. The latest episode of Deloitte Insights features a conversation among Terry Hisey, vice chairman and Life Sciences leader, Deloitte LLP, and Ralph Marcello, principal, and Krithika Ramamoorthy, manager, both with Deloitte Consulting LLP, and Sean OGrady, Insights moderator. Tune in to learn more about the impact of health care reform on the life sciences industry.
